http://www.novartis.com/newsroom/news/feature-stories.shtml Read in-depth stories about how Novartis is addressing the changing needs of patients and societies worldwide. en /newsroom/news/2010-07-26_nitd-nvgh.shtml Novartis is pioneering medicines for neglected diseases, with institutes focusing solely on diseases for which research was virtually non-existent. Thu, 05 Aug 2010 21:15:00 GMT+1 /newsroom/news/2010-07-26_herrling.shtml Novartis is leading industry efforts to fill a multi-billion-dollar gap in neglected disease R&D funding. Thu, 05 Aug 2010 21:15:00 GMT+1 http://www.novartis.com/newsroom/news/2010-06-21_un-global-compact.shtml See Novartis Chairman Daniel Vasella, M.D., discuss the values and principles of the United Nations Global Compact on its 10th anniversary. Wed, 23 Jun 2010 14:45:00 GMT+1 http://www.novartis.com/newsroom/news/2010-06-21_klaus-leisinger.shtml In a wide-ranging interview, Klaus Leisinger describes how Novartis embodies the principles of the United Nations Global Compact. Wed, 23 Jun 2010 14:45:00 GMT+1 http://www.novartis.com/newsroom/news/2010-06-21_keith-saveal.shtml Keith Saveal, Head of Corporate Health, Safety and Environment & Business Continuity, recounts the evolution of the new UN Environmental Stewardship Strategy. Wed, 23 Jun 2010 14:45:00 GMT+1 http://www.novartis.com/newsroom/news/2010-05-21_ciba-vision.shtml Eye care professionals are benefiting from an innovative new iPhone® application offering “anytime, anywhere” access to high-quality educational resources. Fri, 21 May 2010 19:00:00 GMT+1 http://www.novartis.com/newsroom/news/2010-04-23_malaria.shtml On World Malaria Day, April 25, the international community highlights the campaign to provide effective control of this deadly disease. Thu, 23 Apr 2010 09:55:00 GMT+1 http://www.novartis.com/newsroom/news/2010-04-22_ms.shtml People with multiple sclerosis (MS) face devastating uncertainty, not knowing how the disease will progress or disrupt their daily lives. But scientists are developing new diagnostic tools to aid treatment and ease the unpredictability for patients. Thu, 22 Apr 2010 14:07:00 GMT+1 http://www.novartis.com/newsroom/news/2010-02-27_vaxtrak.shtml Novartis Vaccines and Diagnostics (NV&D) has developed a way to help parents, families and vaccine consumers track vaccinations using the iPhone®. Thu, 18 Feb 2010 19:15:00 GMT+1 http://www.novartis.com/newsroom/news/2010-01-26_pharmaceutical-portfolio.shtml Just as new medicines are improving the lives of patients fighting serious diseases, success in innovation is rejuvenating the portfolio of Novartis. Recently launched products grew to 16% of net sales for the Pharmaceuticals Division in 2009. Tue, 26 Jan 2010 07:05:00 GMT+1 http://www.novartis.com/newsroom/news/2010-01-22_haiti.shtml Novartis joins urgent relief efforts for victims of earthquake in Haiti offering aid in the form of financial support to relief organizations and donations of essential medicines. Fri, 22 Jan 2010 11:15:00 GMT+1 http://www.novartis.com/newsroom/news/2010-01-14_legal-team.shtml In times of global financial uncertainty, the Novartis legal team takes an innovative approach – serving as both a protective guardian and a proactive partner to the business. Thu, 14 Jan 2010 21:15:00 GMT+1 http://www.novartis.com/newsroom/news/2009-11-25_biocamp.shtml Today’s best young minds will soon be changing the world. Novartis has created a unique global initiative encouraging top students to apply their intellects in the biotechnology industry – and to think like entrepreneurs. Wed, 25 Nov 2009 17:25:00 GMT+1 http://www.novartis.com/newsroom/news/2009-11-25_corporate-governance.shtml A board of directors can restore confidence in the wake of a financial meltdown. On a panel at Yale University, Novartis General Counsel Thomas Werlen helps outline the qualities of a successful board. Wed, 25 Nov 2009 17:25:00 GMT+1 http://www.novartis.com/newsroom/news/2009-11-12_heartburn.shtml More than 50 million American adults suffer from frequent heartburn. Painful symptoms can disrupt their lives. Now Novartis Consumer Health offers Prevacid®24HR, a new way to treat frequent heartburn over-the-counter. Thu, 12 Nov 2009 08:55:00 GMT+1 http://www.novartis.com/newsroom/news/2009-10-19_ms.shtml Recent advances in science are enabling new treatments with greater efficacy and more convenient delivery. Novartis is investing significant resources to deliver these treatments to patients with MS. Mon, 19 Oct 2009 13:00:00 GMT+1 http://www.novartis.com/newsroom/news/2009-10-01-onsior.shtml An innovative new Novartis product brings fast, effective relief of pain and inflammation for pets. Onsior®, launched in Europe, is the first medication of its class for cats and dogs. The range of dosing options offer convenience for veterinarians and pet owners. Thu, 01 Oct 2009 16:25:00 GMT+1 http://www.novartis.com/newsroom/news/2009-09-08_fight-against-leprosy.shtml The once-dreaded disease leprosy is on the brink of elimination, but the fight goes on. Novartis commemorates 20 years of helping deliver free care, drugs and rehabilitation in India. Tue, 08 Sep 2009 16:50:00 GMT+1 http://www.novartis.com/newsroom/news/2009-07-21_energy-efficiency.shtml World leaders are focused on climate change and Novartis is, too. Our cutting-edge energy efficiency strategy is a driving long-term success for the environment and for our business. Wed, 22 Jul 2009 11:15:00 GMT+1 http://www.novartis.com/newsroom/news/2009-05-20_european-inventor.shtml Scientists who developed Novartis Coartem® and Glivec® receive 2009 "European Inventor of the Year" awards. Wed, 20 May 2009 14:00:00 GMT+1 http://www.novartis.com/newsroom/news/2009-04-24_malaria.shtml April 25 is World Malaria Day, an opportunity to reflect on the progress made in finding sustainable solutions for malaria. Fri, 24 Apr 2009 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2009-03-31_zolvix.shtml With declining efficacy and resistance to existing sheep worm treatments on the rise, Novartis Animal Health worked together with sheep farmers and veterinarians to develop an unparalleled new treatment. Tue, 31 Mar 2009 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2009-03-19_world-tuberculosis-day.shtml As World TB Day on March 24 raises global awareness, Novartis remains a committed partner in the struggle. Thu, 19 Mar 2009 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2009-02-27_rare-disease-day.shtml The challenges of developing products in rare diseases are many - but no obstacle for Novartis Development teams. Fri, 27 Feb 2009 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2009-02-04_egm.shtml Novartis is working to expand its offering in emerging markets including Brazil, Russia, India and China. Wed, 04 Feb 2009 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2008-12-18_nitd_tropical_diseases.shtml The Novartis Institute for Tropical Diseases aims to discover novel treatments and prevention methods for major tropical diseases. Thu, 18 Dec 2008 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2008-11-10_world-diabetes-day.shtml The Novartis lighting ceremony demonstrates the commitment of the company in providing innovative therapies for the treatment of diabetes. Mon, 10 Nov 2008 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2008-06-16_tb-symposium.shtml Once thought a disease of the past, tuberculosis is again becoming an international health threat. Mon, 16 Jun 2008 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2008-04-25_world-malaria-day.shtml Novartis is part of a multi-agency partnership supporting an ambitious journey along the Zambezi River, highlighting the difficulty of delivering mosquito nets and malaria treatment to remote African communities. Fri, 25 Apr 2008 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2008-03-19_nvgh.shtml Many eminent scientists are contributing to the Novartis Vaccines Institute for Global Health, the first research center established by a major vaccine manufacturer with a nonprofit mission - to discover and develop vaccines for "neglected" diseases of the developing world. Wed, 19 Mar 2008 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2008-02-28_rare-disease-day.shtml Rare diseases affect nearly 36 million people in the European Union alone. Learn more about this pioneer initiative in Europe to raise awareness of rare diseases and the Novartis commitment to address unmet needs. Thu, 28 Feb 2008 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2008-01-25_leprosy.shtml Novartis and the Novartis Foundation for Sustainable Development are working toward the elimination of leprosy. "Toward a world without leprosy" was the motto of the 17th International Leprosy Congress in Hyderabad, India. Fri, 25 Jan 2008 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2007-11-22-renin.shtml When Soren Anderson opened his morning newspaper recently, he noticed a headline about an award-winning new medicine. As he read the article, Soren grew intrigued by the thought that this new medicine that fights high blood pressure in a unique way might help in his long fight against the disease. Thu, 22 Nov 2007 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2007-08-13_nitd.shtml The Novartis Institute for Tropical Diseases (NITD), part of Novartis Corporate Research, set out five years ago to apply leading-edge tools of biomedical research to tropical diseases such as dengue fever and tuberculosis that take a daunting toll among patients in the developing world. Mon, 13 Aug 2007 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2007-06-26_dengue-fever.shtml As part of the Singapore Dengue Consortium, the Novartis Institute for Tropical Diseases (NITD) and 10 other scientific bodies will share information and findings to better understand the virus which causes fever, severe joint pain and in some cases hemorrhage, shock and death. Tue, 26 Jun 2007 00:00:00 GMT+1 http://www.novartis.com/newsroom/news/2007-04-17_coartem-africa.shtml The main battleground is Africa, where malaria kills more than a million people every year, mainly pregnant women and children younger than five years of age. "Malaria is more than an ordinary disease on this continent," says the Honorable Richard Nduhura, Uganda's Minister of State for Health. Tue, 17 Apr 2007 00:00:00 GMT+1